阿瓦諾斯醫療公司
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership1,972,523 shares
Latest Disclosed Value $ 27,635,047
State Street Corp reports 0.91% increase in ownership of AVNS / Avanos Medical, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 1,972,523 shares of Avanos Medical, Inc. (US:AVNS) valued at $27,635,047 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,954,785 shares of Avanos Medical, Inc.. This represents a change in shares of 0.91% during the quarter. The current value of the position is $49,411,701 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVANOS MED COM 05350V106 1,972,523 17,738 0.91 27,635 25.89 0.0010
2026-02-13 2025-12-31 13F AVANOS MED COM 05350V106 1,954,785 53,523 2.82 21,952 -0.12 0.0007
2025-11-14 2025-09-30 13F AVANOS MED COM 05350V106 1,901,262 -16,260 -0.85 21,979 -6.36 0.0008
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 1,917,522 -11,799 -0.61 23,470 -15.11 0.0009
2025-05-15 2025-03-31 13F AVANOS MED COM 05350V106 1,929,321 -30,802 -1.57 27,647 -11.40 0.0011
2025-02-14 2024-12-31 13F AVANOS MED COM 05350V106 1,960,123 138,239 7.59 31,205 -28.72 0.0012
2024-11-14 2024-09-30 13F AVANOS MED COM 05350V106 1,821,884 -2,451 -0.13 43,780 20.47 0.0018
2024-08-14 2024-06-30 13F AVANOS MED COM 05350V106 1,824,335 -151,499 -7.67 36,341 -7.62 0.0016
2024-05-15 2024-03-31 13F AVANOS MED COM 05350V106 1,975,834 12,958 0.66 39,339 -10.65 0.0018
2024-02-14 2023-12-31 13F AVANOS MED COM 05350V106 1,962,876 -26,880 -1.35 44,027 9.43 0.0021
2023-11-14 2023-09-30 13F AVANOS MED COM 05350V106 1,989,756 -57,563 -2.81 40,233 -23.12 0.0022
2023-08-14 2023-06-30 13F AVANOS MED COM 05350V106 2,047,319 22,488 1.11 52,329 -13.10 0.0027
2023-05-15 2023-03-31 13F AVANOS MED COM 05350V106 2,024,831 699 0.03 60,218 9.94 0.0034
2023-05-15 2022-12-31 13F/A-99 AVANOS MED COM 05350V106 2,024,132 18,537 0.92 54,773 25.39 0.0032
2023-05-15 2022-12-31 13F AVANOS MED COM 05350V106 2,024,132 18,537 54,773 0.0032
2022-11-15 2022-09-30 13F AVANOS MED COM 05350V106 2,005,595 -4,457 -0.22 43,682 -20.51 0.0028
2022-08-15 2022-06-30 13F AVANOS MED COM 05350V106 2,010,052 -8,653 -0.43 54,955 -18.74 0.0033
2022-05-16 2022-03-31 13F AVANOS MED COM 05350V106 2,018,705 9,410 0.47 67,627 -2.92 0.0033
2022-02-14 2021-12-31 13F AVANOS MED COM 05350V106 2,009,295 119,168 6.30 69,662 18.13 0.0033
2021-11-15 2021-09-30 13F AVANOS MED COM 05350V106 1,890,127 95,688 5.33 58,972 -9.64 0.0031
2021-08-16 2021-06-30 13F AVANOS MED COM 05350V106 1,794,439 107,614 6.38 65,264 -11.54 0.0034
2021-07-09 2021-03-31 13F/A-1 AVANOS MED COM 05350V106 1,686,825 19,835 1.19 73,782 -3.53 0.0042
2021-05-17 2021-03-31 13F AVANOS MED COM 05350V106 1,686,825 19,835 73,782 0.0042
2021-02-16 2020-12-31 13F AVANOS MED COM 05350V106 1,666,990 -53,543 -3.11 76,482 33.81 0.0047
2020-11-10 2020-09-30 13F AVANOS MED COM 05350V106 1,720,533 -70,140 -3.92 57,156 8.60 0.0039
2020-08-14 2020-06-30 13F AVANOS MED COM 05350V106 1,790,673 7,419 0.42 52,628 9.59 0.0038
2020-06-19 2020-03-31 13F/A-1 AVANOS MED COM 05350V106 1,783,254 -26,335 -1.46 48,023 -21.25 0.0042
2020-05-11 2020-03-31 13F AVANOS MED COM 05350V106 1,783,254 -26,335 48,023 4,217.3864
2020-02-06 2019-12-31 13F AVANOS MED COM 05350V106 1,809,589 34,588 1.95 60,983 -8.29 0.0042
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 1,775,001 -154,957 -8.03 66,492 -21.00 0.0050
2019-08-14 2019-06-30 13F AVANOS MED COM 05350V106 1,929,958 3,342 0.17 84,165 2.36 0.0063
2019-05-15 2019-03-31 13F AVANOS MED COM 05350V106 1,926,616 85,908 4.67 82,228 -0.26 0.0064
2019-02-12 2018-12-31 13F AVANOS MED COM 05350V106 1,840,708 -50,335 -2.66 82,445 -36.35 0.0075
2018-11-09 2018-09-30 13F AVANOS MEDICAL Common equity shares 05350V106 1,891,043 117,125 6.60 129,537 27.37 0.0099
2018-08-14 2018-06-30 13F HALYARD HEALTH Common equity shares 40650V100 1,773,918 88,974 5.28 101,700 30.98 0.0085
2018-05-15 2018-03-31 13F HALYARD HEALTH Common equity shares 40650V100 1,684,944 -19,600 -1.15 77,644 -1.36 0.0066
2018-02-14 2017-12-31 13F HALYARD HEALTH Common equity shares 40650V100 1,704,544 19,584 1.16 78,717 3.75 0.0063
2017-11-14 2017-09-30 13F HALYARD HEALTH Common equity shares 40650V100 1,684,960 -17,463 -1.03 75,873 13.46 0.0065
2017-08-14 2017-06-30 13F HALYARD HEALTH Common equity shares 40650V100 1,702,423 119,154 7.53 66,872 10.89 0.0059
2017-05-15 2017-03-31 13F HALYARD HEALTH Common equity shares 40650V100 1,583,269 28,718 1.85 60,306 4.90 0.0054
2017-02-09 2016-12-31 13F HALYARD HEALTH Common equity shares 40650V100 1,554,551 -27,621 -1.75 57,487 4.82 0.0054
2017-01-13 2016-09-30 13F/A-1 HALYARD HEALTH Common equity shares 40650V100 1,582,172 59,316 3.90 54,842 10.73 0.0055
2016-11-14 2016-09-30 13F HALYARD HEALTH Common equity shares 40650V100 1,582,172 54,842
2016-08-12 2016-06-30 13F HALYARD HEALTH Common equity shares 40650V100 1,522,856 13,220 0.88 49,529 14.19 0.0053
2016-05-20 2016-03-31 13F/A-1 HALYARD HEALTH Common equity shares 40650V100 1,509,636 -25,994 -1.69 43,375 -15.44 0.0047
2016-05-12 2016-03-31 13F HALYARD HEALTH Common equity shares 40650V100 1,509,636 43,375
2016-02-16 2015-12-31 13F HALYARD HEALTH Common equity shares 40650V100 1,535,630 8,710 0.57 51,297 18.13 0.0056
2015-11-16 2015-09-30 13F HALYARD HEALTH Common equity shares 40650V100 1,526,920 -36,972 -2.36 43,424 -31.44 0.0051
2015-08-13 2015-06-30 13F HALYARD HEALTH Common equity shares 40650V100 1,563,892 198,589 14.55 63,340 -5.71 0.0068
2015-05-15 2015-03-31 13F HALYARD HEALTH Common equity shares 40650V100 1,365,303 6,951 0.51 67,174 8.75 0.0069
2015-02-11 2014-12-31 13F HALYARD HEALTH Common equity shares 40650V100 1,358,352 1,358,352 61,769 0.0062
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.